The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

Share Price Information for Jaywing (JWNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.15
Bid: 3.10
Ask: 3.20
Change: 0.00 (0.00%)
Spread: 0.10 (3.226%)
Open: 3.15
High: 3.15
Low: 3.15
Prev. Close: 3.15
JWNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

30 Sep 2016 15:22

RNS Number : 3951L
Jaywing PLC
30 September 2016
 

Date: Friday 30 September 2016

On behalf of: Jaywing plc ("the Company" or "the Group")

 

Jaywing plc

("Jaywing" or "the Company")

Grant of options

Director/PDMR Shareholding

 

The Company announces the following grants of options to its Executive Directors (the "New Options") under its performance share plan ("PSP"):

 

Director

Position

Options vested under previous scheme

Number of New Options granted

Exercise price

Total numberof optionsheld followinggrant

Rob Shaw

CEO UK & Australia

124,869

1,591,054

5p

1,715,923

Adrian Lingard

COO

61,000

1,156,303

5p

1,217,303

Michael Sprot

CFO

-

710,000

5p

710,000

Martin Boddy

CEO

-

496,000

5p

496,000

Andy Gardner

CSO

-

496,000

5p

496,000

Total

 

185,869

4,449,357

 

4,635,226

 

The grants to Rob Shaw (CEO UK & Australia) and Adrian Lingard (COO) follow their appointment to the Board of Jaywing in July 2015 and aim to provide a suitable long term incentive. The grant to Michael Sprot reflects his promotion to CFO. The New Options granted to Martin Boddy, Andy Gardner and Michael Sprot replace the options previously granted to them in March 2015 which have now been cancelled. The New Options issued to Rob Shaw and Adrian Lingard replace 566,131 and 348,000 respectively of their previous options which had not vested and have now been cancelled. Vested options not yet exercised from a previous scheme for Rob Shaw and Adrian Lingard amount to 124,869 and 61,000 respectively. The grants of New Options are designed to align incentives for all the Executive Directors to the longer term interests of shareholders.

 

These grants had previously been considered by the Remuneration Committee prior to the Company entering into a close period relating to the recently announced acquisitions, and are now being granted following the end of the close period.

 

The New Options have a number of vesting criteria designed to retain and incentivise the Executive Management team. Vesting criteria includes EBITDA growth, share price targets and ongoing commitment to the business. The New Options vest over a three year period to 31 July 2019 and are exercisable until 31 July 2020.

 

Following the grant of New Options the total number of options outstanding is 8,235,739 representing approximately 9.5 per cent of the Company's existing issued share capital being 86,359,385 ordinary shares.

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation, and gives further detail.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rob Shaw

2

Reason for the notification

a)

Position/status

Chief Executive Officer / Director and a PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Jaywing plc

b)

LEI

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p each in Jaywing plc ("Shares")

 

ISIN: GB00B1FPT107

b)

Nature of the transaction

Grant of options under the Jaywing plc Performance Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.05 option exercise price

1,591,054

d)

Aggregated information

- Aggregated volume

- Price

 N/A

e)

Date of the transaction

 30 September 2016

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adrian Lingard

2

Reason for the notification

a)

Position/status

Chief Operating Officer / Director and a PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Jaywing plc

b)

LEI

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p each in Jaywing plc ("Shares")

 

ISIN: GB00B1FPT107

b)

Nature of the transaction

Grant of options under the Jaywing plc Performance Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.05 option exercise price

1,156,303

d)

Aggregated information

- Aggregated volume

- Price

 N/A

e)

Date of the transaction

 30 September 2016

f)

Place of the transaction

London Stock Exchange

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Sprot

2

Reason for the notification

a)

Position/status

Chief Financial Officer / Director and a PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Jaywing plc

b)

LEI

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p each in Jaywing plc ("Shares")

 

ISIN: GB00B1FPT107

b)

Nature of the transaction

Grant of options under the Jaywing plc Performance Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.05 option exercise price

710,000

d)

Aggregated information

- Aggregated volume

- Price

 N/A

e)

Date of the transaction

 30 September 2016

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Martin Boddy

2

Reason for the notification

a)

Position/status

Chief Executive Officer / Director and a PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Jaywing plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p each in Jaywing plc ("Shares")

 

ISIN: GB00B1FPT107

b)

Nature of the transaction

Grant of options under the Jaywing plc Performance Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.05 option exercise price

496,000

d)

Aggregated information

- Aggregated volume

- Price

 N/A

e)

Date of the transaction

 30 September 2016

f)

Place of the transaction

London Stock Exchange

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andy Gardner

2

Reason for the notification

a)

Position/status

Chief Strategy Officer / Director and a PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Jaywing plc

b)

LEI

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p each in Jaywing plc ("Shares")

 

ISIN: GB00B1FPT107

b)

Nature of the transaction

Grant of options under the Jaywing plc Performance Share Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.05 option exercise price

496,000

d)

Aggregated information

- Aggregated volume

- Price

 N/A

e)

Date of the transaction

 30 September 2016

f)

Place of the transaction

London Stock Exchange

 

 

 

Enquiries:Jaywing plcMichael Sprot (Company Secretary) Tel: 0114 281 1200

 

Cenkos Securities plc

Ivonne Cantu/Callum Davidson(Nomad) Tel: 0207 397 8920

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMGFLDGRGVZM
Date   Source Headline
10th Dec 202011:30 amRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSHalf-year Report
26th Nov 20207:00 amRNSFinal Results
21st Oct 20207:00 amRNSExercise and completion of put option
29th Sep 20201:37 pmRNSResult of AGM
4th Sep 202010:05 amRNSNotice of AGM
26th Aug 20207:00 amRNSAppointment of CFO & Trading Update
29th Jul 20208:58 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSDirectorate Change
26th Mar 20207:00 amRNSDirectorate Change
24th Mar 20207:00 amRNSDirectorate Change
18th Mar 20205:25 pmRNSAIM Rule 17 Notification
27th Jan 20207:00 amRNSDirectorate Change
20th Dec 20197:00 amRNSHalf-year Report
8th Nov 20199:10 amRNSHolding(s) in Company
8th Oct 20193:20 pmRNSNotice of GM
2nd Oct 20192:06 pmRNSPublication of Notice of AGM
2nd Oct 20197:00 amRNSFurther re. trading update & related party
30th Sep 20193:44 pmRNSResult of AGM
30th Sep 20197:00 amRNSAnnual Financial Report
26th Sep 20192:06 pmRNSSecond Price Monitoring Extn
26th Sep 20192:00 pmRNSPrice Monitoring Extension
13th Sep 201911:05 amRNSSecond Price Monitoring Extn
13th Sep 201911:00 amRNSPrice Monitoring Extension
12th Sep 20194:40 pmRNSSecond Price Monitoring Extn
12th Sep 20194:35 pmRNSPrice Monitoring Extension
11th Sep 20192:05 pmRNSSecond Price Monitoring Extn
11th Sep 20192:00 pmRNSPrice Monitoring Extension
30th Aug 20197:00 amRNSFurther re. trading update and results
6th Aug 20191:30 pmRNSAIM Rule 17 Notification
18th Jul 20195:07 pmRNSHolding(s) in Company
10th Jul 201911:37 amRNSTrading Statement
13th May 20197:00 amRNSAwards
2nd May 20197:00 amRNSTrading Statement
19th Feb 201911:32 amRNSHolding(s) in Company
10th Jan 20197:00 amRNSCompletion of Disposal
20th Nov 20187:01 amRNSHalf-year Report
20th Nov 20187:00 amRNSDisposal
29th Oct 20184:10 pmRNSHolding(s) in Company
11th Sep 20181:46 pmRNSResult of AGM and Trading Update
29th Aug 20187:00 amRNSClient Wins
16th Aug 20187:00 amRNSAnnual Financial Report
10th Jul 20189:41 amRNSFinal Results - Replacement
10th Jul 20187:00 amRNSFinal Results
25th Apr 20187:00 amRNSTrading Statement and Full Year Results Date
28th Mar 20184:03 pmRNSHolding(s) in Company
16th Mar 201810:28 amRNSHolding(s) in Company
15th Mar 20188:18 amRNSDirector/PDMR Shareholding
14th Mar 201812:06 pmRNSResult of General Meeting
27th Feb 20183:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.